JP2014015483A5 - - Google Patents

Download PDF

Info

Publication number: JP2014015483A5
Authority: JP; Japan
Prior art keywords: compound; formula; compound according; complex; triethylenediamine
Prior art date: 2013-10-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP2013219880A

Other languages

English (en)

Japanese (ja)

Other versions

JP6148594B2 (ja

JP2014015483A (ja

Filing date

2013-10-23

Publication date

2014-12-04

2013-10-23 Application filed filed Critical

2014-01-30 Publication of JP2014015483A publication Critical patent/JP2014015483A/ja

2014-12-04 Publication of JP2014015483A5 publication Critical patent/JP2014015483A5/ja

2017-06-14 Application granted granted Critical

2017-06-14 Publication of JP6148594B2 publication Critical patent/JP6148594B2/ja

Status Expired - Fee Related legal-status Critical Current

2028-08-01 Anticipated expiration legal-status Critical

Links

JP2013219880A 2007-08-02 2013-10-23 Ｅ１活性化酵素阻害剤の合成のためのプロセス Expired - Fee Related JP6148594B2 (ja)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US96300807P	2007-08-02	2007-08-02
US60/963,008		2007-08-02
US6237808P	2008-01-25	2008-01-25
US61/062,378		2008-01-25

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2010519947A Division JP5479336B2 (ja)	2007-08-02	2008-08-01	Ｅ１活性化酵素阻害剤の合成のためのプロセス

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2014215250A Division JP2015025009A (ja)	2007-08-02	2014-10-22	Ｅ１活性化酵素阻害剤の合成のためのプロセス

Publications (3)

Publication Number	Publication Date
JP2014015483A JP2014015483A (ja)	2014-01-30
JP2014015483A5 true JP2014015483A5 (2)	2014-12-04
JP6148594B2 JP6148594B2 (ja)	2017-06-14

Family

ID=40225413

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
JP2010519947A Expired - Fee Related JP5479336B2 (ja)	2007-08-02	2008-08-01	Ｅ１活性化酵素阻害剤の合成のためのプロセス
JP2013219880A Expired - Fee Related JP6148594B2 (ja)	2007-08-02	2013-10-23	Ｅ１活性化酵素阻害剤の合成のためのプロセス
JP2014215250A Pending JP2015025009A (ja)	2007-08-02	2014-10-22	Ｅ１活性化酵素阻害剤の合成のためのプロセス

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
JP2010519947A Expired - Fee Related JP5479336B2 (ja)	2007-08-02	2008-08-01	Ｅ１活性化酵素阻害剤の合成のためのプロセス

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
JP2014215250A Pending JP2015025009A (ja)	2007-08-02	2014-10-22	Ｅ１活性化酵素阻害剤の合成のためのプロセス

Country Status (14)

Country	Link
US (3)	US8933225B2 (2)
EP (4)	EP2546256B1 (2)
JP (3)	JP5479336B2 (2)
KR (2)	KR20100066475A (2)
CN (3)	CN101868461B (2)
AU (1)	AU2008305767B2 (2)
CA (2)	CA2949336C (2)
ES (4)	ES2684309T3 (2)
IL (2)	IL203590A (2)
MX (1)	MX2010001126A (2)
RU (2)	RU2015108944A (2)
TW (2)	TW201434851A (2)
WO (1)	WO2009042013A1 (2)
ZA (1)	ZA201000482B (2)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009042013A1 (en)	2007-08-02	2009-04-02	Millennium Pharmaceuticals, Inc.	Process for the synthesis of e1 activating enzyme inhibitors
SG175929A1 (en)	2009-05-14	2011-12-29	Millennium Pharm Inc	Hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
JP2013541587A (ja) *	2010-11-05	2013-11-14	ミレニアムファーマシューティカルズ，インコーポレイテッド	Ｎｅｄｄ８活性化酵素阻害剤の投与
CN104136399B (zh) *	2012-02-17	2018-08-07	米伦纽姆医药公司	泛素活化酶的吡唑并嘧啶基抑制剂
CN104072381B (zh) *	2013-03-26	2017-04-12	安徽贝克联合制药有限公司	光学纯氨基醇盐酸盐的制备方法
CA2923752A1 (en)	2013-05-14	2014-11-20	Millennium Pharmaceuticals, Inc.	Administration of nedd8-activating enzyme inhibitor and chemotherapeutic agents
BR112016030787B1 (pt)	2014-07-01	2022-12-20	Takeda Pharmaceutical Company Limited	Entidade química, composição farmacêutica e seu uso
TW201628621A (zh)	2014-10-29	2016-08-16	千禧製藥公司	泛素活化酶抑制劑及輻射之施用
CN104974051A (zh) *	2015-06-30	2015-10-14	苏州开元民生科技股份有限公司	(1S,4R)-cis-4-氨基-2-环戊烯-1-甲醇盐酸盐的合成方法
CN106854208B (zh) *	2016-11-25	2019-04-09	成都柏睿泰生物科技有限公司	肿瘤抑制剂mln4924的合成方法
WO2019060536A1 (en)	2017-09-21	2019-03-28	Millennium Pharmaceuticals, Inc.	CO-CRYSTALLINE FORMS OF ((1S, 2S, 4R) -4- {4 - [(1S) -2,3-DIHYDRO-1H-INDEN-1-YLAMINO] -7H-PYRROLO [2,3-D] PYRIMIDIN -7-YL} -2-HYDROXYCYCLOPENTYL) METHYLSULFAMATE, THEIR FORMULATIONS AND USES
KR102018341B1 (ko) *	2018-06-21	2019-09-04	성균관대학교산학협력단	RNF170 및 pUL50을 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물
MA55556A (fr)	2019-04-02	2022-02-09	Aligos Therapeutics Inc	Composés ciblant prmt5
US12520610B2 (en) *	2020-05-26	2026-01-06	Sony Semiconductor Solutions Corporation	Ranging device
WO2022112951A1 (en)	2020-11-25	2022-06-02	Takeda Pharmaceutical Company Limited	Solid state forms of hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4138433A (en) *	1975-06-26	1979-02-06	Hoechst Aktiengesellschaft	Process for preparing 1,2-oxa-phospholanes
US4081455A (en) *	1976-06-02	1978-03-28	Pfizer Inc.	6-Amino-2,2-dimethyl-3-cyanopenams
US4803272A (en) *	1987-02-24	1989-02-07	E. I. Du Pont De Nemours And Company	S-modified adenosyl-1,8-diamino-3-thiooctane derivatives
US4927830A (en) *	1988-04-08	1990-05-22	The Regents Of The University Of Michigan	Acyclic pyrrolo[2,3-D]pyrimidine analogs as antiviral agents
GB9204015D0 (en)	1992-02-25	1992-04-08	Wellcome Found	Therapeutic nucleosides
GB9205071D0 (en) *	1992-03-09	1992-04-22	Wellcome Found	Therapeutic nucleosides
HUT77440A (hu)	1994-09-09	1998-04-28	The Regents Of The University Of Michigan	Karbociklusos gyűrűhöz kapcsoló benzimidazolokat tartalmazó vírus-ellenes nukleozid analógok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
US5912356A (en) *	1995-09-11	1999-06-15	Glaxo Wellcome Inc.	Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring
DK1040094T3 (da)	1997-12-17	2009-06-02	Biocryst Pharm Inc	Substitueret cyklopentan og cyklopenten-forbindelser anvendelige som neuraminidase-inhibitorer
US6878716B1 (en) *	1998-06-02	2005-04-12	Osi Pharmaceuticals, Inc.	Compounds specific to adenosine A1 receptor and uses thereof
US6379552B1 (en) *	1998-07-06	2002-04-30	Toray Industries, Inc.	Method for resolving optical isomers
JP2000290201A (ja) *	1998-07-06	2000-10-17	Toray Ind Inc	光学異性体の分割方法
GB9907082D0 (en)	1999-03-26	1999-05-19	Chirotech Technology Ltd	The preparation of carboxylic acid derivatives
CO5261573A1 (es) *	1999-11-19	2003-03-31	Novartis Ag	Derivados de benzoxa y bezotiazol, compuesto y composicion farmaceutica que los contiene y proceso para la preparacion de la mencionada composicion
WO2001042255A1 (en)	1999-12-10	2001-06-14	Glaxo Group Limited	(1R,CIS)-4-(4-AMINO-7H-PYRROLO'2,3-I(D) &excl; PYRIMIDINE-7-YL)-2-CYCLOPENTENE-1-METHANOL DERIVATIVES AS ANTIVIRAL
BR0016415A (pt) *	1999-12-16	2002-12-24	Alcon Inc	Inibidores de adenosina cinase para o tratamento de dano retinal e de nervo ótico
ES2256576T3 (es) *	2001-12-21	2006-07-16	Schering Aktiengesellschaft	Proceso aplicable industrialmente para la sulfamoilacion de alcoholes y fenoles.
WO2003105770A2 (en)	2002-06-17	2003-12-24	Merck & Co., Inc.	Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
AU2003248708A1 (en) *	2002-06-17	2003-12-31	Isis Pharmaceuticals, Inc.	Oligomeric compounds that include carbocyclic nucleosides and their use in gene modulation
GB0225986D0 (en) *	2002-11-07	2002-12-11	Astrazeneca Ab	Chemical compounds
US7429596B2 (en) *	2003-06-20	2008-09-30	The Regents Of The University Of California	1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
US7338957B2 (en) *	2003-08-28	2008-03-04	Irm Llc	Compounds and compositions as protein kinase inhibitors
CN101693695A (zh) *	2004-03-30	2010-04-14	大正制药株式会社	嘧啶衍生物以及与其应用有关的治疗方法
EP1736467A4 (en) *	2004-04-06	2009-07-01	Dainippon Sumitomo Pharma Co	NEW SULFONIC ACID AMID DERIVATIVE
CA2471666C (en)	2004-06-18	2009-10-13	Apotex Pharmachem Inc.	An improved process for the preparation of oxcarbazepine and related intermediates
PT1848718E (pt) *	2005-02-04	2012-10-11	Millennium Pharm Inc	Inibidores de enzimas de activação e1
KR101450535B1 (ko) *	2006-02-02	2014-10-14	밀레니엄 파머슈티컬스 인코퍼레이티드	Ｅ１ 활성화 효소의 억제제
EA201501088A1 (ru) *	2006-08-08	2017-01-30	Миллениум Фармасьютикалз, Инк.	Гетероарильные соединения, применяемые в качестве ингибиторов e1 активирующих ферментов
US8008307B2 (en) *	2006-08-08	2011-08-30	Millennium Pharmaceuticals, Inc.	Heteroaryl compounds useful as inhibitors of E1 activating enzymes
WO2009042013A1 (en)	2007-08-02	2009-04-02	Millennium Pharmaceuticals, Inc.	Process for the synthesis of e1 activating enzyme inhibitors
SG175929A1 (en) *	2009-05-14	2011-12-29	Millennium Pharm Inc	Hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate

2008
- 2008-08-01 WO PCT/US2008/009338 patent/WO2009042013A1/en not_active Ceased
- 2008-08-01 TW TW102143875A patent/TW201434851A/zh unknown
- 2008-08-01 ES ES12172365.4T patent/ES2684309T3/es active Active
- 2008-08-01 RU RU2015108944/04A patent/RU2015108944A/ru not_active Application Discontinuation
- 2008-08-01 AU AU2008305767A patent/AU2008305767B2/en not_active Ceased
- 2008-08-01 KR KR1020107004735A patent/KR20100066475A/ko not_active Ceased
- 2008-08-01 US US12/221,399 patent/US8933225B2/en not_active Expired - Fee Related
- 2008-08-01 CN CN2008801015257A patent/CN101868461B/zh not_active Expired - Fee Related
- 2008-08-01 EP EP12172363.9A patent/EP2546256B1/en active Active
- 2008-08-01 CA CA2949336A patent/CA2949336C/en not_active Expired - Fee Related
- 2008-08-01 ES ES12172364T patent/ES2758027T3/es active Active
- 2008-08-01 ES ES08832973.5T patent/ES2655028T3/es active Active
- 2008-08-01 CN CN201610622354.9A patent/CN106243111B/zh not_active Expired - Fee Related
- 2008-08-01 ES ES12172363T patent/ES2757928T3/es active Active
- 2008-08-01 MX MX2010001126A patent/MX2010001126A/es active IP Right Grant
- 2008-08-01 RU RU2010107471/04A patent/RU2553476C2/ru active
- 2008-08-01 TW TW097129447A patent/TWI426077B/zh not_active IP Right Cessation
- 2008-08-01 EP EP08832973.5A patent/EP2178880B1/en active Active
- 2008-08-01 EP EP12172364.7A patent/EP2540726B1/en active Active
- 2008-08-01 EP EP12172365.4A patent/EP2540727B1/en active Active
- 2008-08-01 KR KR1020157014228A patent/KR101925902B1/ko not_active Expired - Fee Related
- 2008-08-01 CA CA2695193A patent/CA2695193C/en not_active Expired - Fee Related
- 2008-08-01 JP JP2010519947A patent/JP5479336B2/ja not_active Expired - Fee Related
- 2008-08-01 CN CN201310356726.4A patent/CN103483342B/zh not_active Expired - Fee Related
2010
- 2010-01-21 ZA ZA2010/00482A patent/ZA201000482B/en unknown
- 2010-01-28 IL IL203590A patent/IL203590A/en active IP Right Grant
2013
- 2013-10-23 JP JP2013219880A patent/JP6148594B2/ja not_active Expired - Fee Related
2014
- 2014-10-22 JP JP2014215250A patent/JP2015025009A/ja active Pending
- 2014-11-25 US US14/552,883 patent/US9802938B2/en not_active Expired - Fee Related
2017
- 2017-03-23 IL IL251372A patent/IL251372B/en active IP Right Grant
- 2017-09-22 US US15/713,293 patent/US10745404B2/en not_active Expired - Fee Related

Publication	Publication Date	Title
JP2014015483A5 (2)	2014-12-04
JP2016512563A5 (2)	2017-04-13
JP2017509689A5 (2)	2018-02-15
JP2012041365A5 (2)	2013-04-04
PE20161475A1 (es)	2017-01-08	Pirazolopiridinas y pirazolopirimidinas
JP2013529196A5 (2)	2014-07-03
JP2009542613A5 (2)	2010-08-05
MX363327B (es)	2019-03-20	Materiales zeoliticos de tipo cha y metodos para su preparacion usando compuestos de cicloalquilamonio.
JP2017535555A5 (2)	2018-12-27
JP2014500870A5 (2)	2014-12-25
AR068057A1 (es)	2009-11-04	Esteres de 1-fenil-2-(3,5-dicloro)-piridina, metodo de preparacion de los mismos, composiciones farmaceuticas que los contienen y usos de los mismos para el tratamiento de enfermedades del tracto respiratorio.
JP2017535614A5 (2)	2018-12-27
JP2015520143A5 (2)	2016-07-07
EP4329431A3 (en)	2024-05-29	Novel heteroleptic iridium complexes
JP2016523955A5 (2)	2017-08-24
JP2018531941A5 (2)	2019-11-21
SG195289A1 (en)	2013-12-30	Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
MY150289A (en)	2013-12-31	Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof
JP2017504635A5 (2)	2018-03-08
JP2013538683A5 (2)	2014-10-30
WO2013004995A8 (en)	2013-03-07	Pyrimidinone compounds and their use
WO2010007318A3 (fr)	2010-04-08	NOUVEAUX DERIVES IMIDAZO[1,2-a]PYRIMIDINE, LEUR PROCEDE DE PREPARATION, LEUR APPLICATION A TITRE DE MEDICAMENTS, COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET
JP2018505205A5 (2)	2019-03-22
JP2017503030A5 (2)	2018-03-01
JP2014520901A5 (2)	2014-10-16